Regional Clinical Research — Endwell, New York

Regional Clinical Research is a clinical research site located in Endwell, New York, United States 13760.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Regional Clinical Research has participated in 60 clinical trials.

Therapeutic areas: Respiratory Tract Infections, Overactive Bladder, Migraine Disorders.

Sponsors: Pfizer, Urovant Sciences GmbH, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Endwell

Browse all research sites in New York · View every site in Endwell

• Meridian Clinical Research
• GSK Investigational Site
• Research Site
• Pfizer Investigational Site
• Meridian Clinical Research (Endwell-New York) - Platinum - PPDS
• Endwell Family Physicians
• Novo Nordisk Investigational Site
• Novartis Investigative Site
• Local Institution
• Endwell Family Physician
• Research Site 10001-128

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regional Clinical Research?

Regional Clinical Research has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regional Clinical Research conducted?

Regional Clinical Research has 60 clinical trials on record. Their work covers Respiratory Tract Infections, Overactive Bladder, Migraine Disorders.

Is Regional Clinical Research accredited by Crixeo Clinical Trials?

Regional Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regional Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.